Nature and frequency of diagnosis of different forms of glomerulonephritis as cause of development and progression of chronic kidney disease in different regions of world, according to clinical and morphological studies with renal biopsy
N. V. Teplova,
G. A. Chervyakova,
A. G. Vardanyan,
S. E. Arakelov,
A. G. Dzheksembekov,
V. V. Apokina https://doi.org/10.33667/2078-5631-2021-25-20-25
Abstract
Hypertensive disorders in pregnant women are a significant factor in the development of complications leading to maternal and perinatal mortality. However, most cases of adverse outcomes are preventable. The choice of drug therapy in this group of patients should be made on the basis of a complete analysis and risk stratification.
Purpose of work. Consideration of modern classification, diagnostic methods and rational antihypertensive therapy of chronic arterial hypertension on the example of a clinical case of a pregnant patient in a therapeutic hospital.
Case description. The presented work describes a case of severe arterial hypertension during the first trimester of pregnancy, poorly amenable to drug correction.
Conclusion. The features of this clinical observation are the problems associated with the selection of antihypertensive therapy for severe arterial hypertension during low gestational age pregnancy, taking into account comorbidities
About the Authors
N. V. Teplova
Russian National Research Medical University n. a. N. I. Pirogov
Russian Federation
Russian Federation
Teplova Natalya V., DM Sci, professor, head of Dept of Clinical Pharmacology, Faculty of General Medicine
Moscow
G. A. Chervyakova
Russian National Research Medical University n. a. N. I. Pirogov
Russian Federation
Russian Federation
Chervyakova Galina A., PhD Med, associate professor at Dept of Clinical Pharmacology, Faculty of General Medicine
Moscow
A. G. Vardanyan
Russian National Research Medical University n. a. N. I. Pirogov
Russian Federation
Russian Federation
Vardanyan Argishti G., assistant at Dept of Clinical Pharmacology, Faculty of General Medicine
Moscow
S. E. Arakelov
City Clinical Hospital No. 13
Russian Federation
Russian Federation
Arakelov Sergei E., DM Sci, chief physician
Moscow
A. G. Dzheksembekov
Russian National Research Medical University n. a. N. I. Pirogov
Russian Federation
Russian Federation
Dzheksembekov Aldar G., assistant at Dept of Clinical Pharmacology, Faculty of General Medicine
Moscow
V. V. Apokina
Russian National Research Medical University n. a. N. I. Pirogov
Russian Federation
Russian Federation
Apokina Valeria V., resident of Dept of Clinical Pharmacology, Faculty of General Medicine
Moscow
References
1. Ghulmiyyah L, Sibai В. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol. 2012 Feb; 36 (1): 56–9.
2. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet, 2010, 21; 376 (9741): 631–442.
3. Say L., Chou D., Gemmill A., Tuncalp., Moller A.-B., Daniels J. et al. Global causes of maternal death: a WHO systematic analysis. The Lancet Global Health. 2014 June; 2 (6): 323–33.
4. Maternal mortality in the Russian Federation in 2014. Methodical letter of the Ministry of Health of the Russian Federation of 09.10.2015. 72 p.
5. ESC Committee for Practice Guidelines. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 2018; doi:10.1093/eurheartj/ehy340.
6. Putilina M. V., Natarova E. B. Features of manifestations of cerebral circulation insufficiency in young patients. Russian medical news; 2002. 1: 41–44.
7. Metelskaya V. A., Oganov R. G., Evsikov E. M. Teplova N. V. The relationship between the level of nitric oxide in peripheral blood serum and the nature of pathology of the cardiovascular system and internal organs in patients with primary arterial hypertension. Russian Journal of Cardiology. 2011, 16 (4): 23–31.
8. Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy: SOGC Clinical Practice Guideline. No. 307, May 2014 (Replaces No. 206, March 2008).
9. ACOG Practice Bulletin No. 125: Chronic hypertension in pregnancy. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2012 Feb; 119 (2 Pt 1): 396–407.
10. Teplova N. V., Lyusov V. N., Oganov R. G., Evsikov E. M., Sharipov R. A. Nephrogenic factors of resistance formation to antihypertensive therapy in patients with primary arterial hypertension; Rational pharmacotherapy in cardiology. 2015; 6 (11): 590–594.
11. Teplova N. V. Vasilip in the treatment of atherosclerosis and hyperlipidemia RMJ 2005:13(2):94–96
12. Shevchenko V. I. Algorithms of emergency medical care outside the medical organization: a manual for medical workers of outreach ambulance teams. St. Petersburg, 2018. 158 p.
13. NICE guideline ‘Hypertension in pregnancy: diagnosis and management’, 2019.
14. Teplova NV, Evsikov EM. The angiotensin receptor blocker Valsartan (Diovan) in clinical practice. RMJ; 2005; 14: 944.
15. Putilina M. V. The role of arterial hypertension in the development of chronic cerebrovascular accident. Journal of Neurology and Psychiatry n. a. S. S. Korsakov. 2014; 114 (9): 124–128.
16. Clinical Recommendations of the Russian Society of Cardiology ‘Arterial hypertension in adults’, 2020.
17. Dodd J. M., Turnbull D., McPhee A.J., Deussen A. R., Grivell R. M., Yelland L. N., Crowther C. A., Wittert G., Owens J. A., Robinson J. S. Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial. BMJ 2014; 348: 1285.
18. Акушерство. Национальное руководство. Под ред. Э. К. Айламазяна, В. И. Кулакова, В. Е. Радзинского и др. М.: ГЭОТАР-медиа, 2009. 1200 с. Obstetrics. National Guide. Edited by E. K. Aylamazyan, V. I. Kulakov, V. E. Radzinsky et al. Moscow: GEOTAR-Media, 2009. 1200 p.
19. Clinical guidelines ‘Diagnosis and treatment of arterial hypertension in pregnant women’, Moscow, 2010.
20. Bellos, V. Pergialiotis, A. Papapanagiotou, D. Loutradis, G. Daskalakis. Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network meta-analysis. American Journal of Obstetrics and Gynecology, Volume 223, Issue 4, 2020, P. 525–537, ISSN 0002–9378, https://doi.org/10.1016/j.ajog.2020.03.016
21. M. Salama, M. Rezk, W. Gaber, H. Hamza, H. Marawan, A. Gamal, S. Abdallah. Methyldopa versus nifedipine or no medication for treatment of chronic hypertension during pregnancy: A multicenter randomized clinical trial. Pregnancy Hypertension, Volume 17, 2019, Pages 54–58, ISSN 2210–7789, https://doi.org/10.1016/j.preghy.2019.05.009.
22. Teplova N. V. Treatment of arterial hypertension with a new form of nifedipine. RMZH; 2004, Vol. 12, 15: 941–944.
23. Sridharan, Kannan, and Reginald P Sequeira. Drugs for treating severe hypertension in pregnancy: A network meta-analysis and trial sequential analysis of randomized clinical trials. British Journal of Clinical Pharmacology. Vol. 84, 9 (2018): 1906–1916. DOI: 10.1111/bcp.13649.
24. Taratukhin E. O., Teplova N. V. Combined antihypertensive therapy: when the whole is greater than the sum. Cardiovascular Therapy and Prevention; 2013; 12(3):68–71.
25. Putilina M. V., Teplova N. V. Medicinal safety as a priority area of domestic medicine. General Medicine. 2019; 4: 7–14. DOI: 10.24411/2071–5315–2019–12152.
Review
For citations:
Teplova N.V., Chervyakova G.A., Vardanyan A.G., Arakelov S.E., Dzheksembekov A.G., Apokina V.V. Nature and frequency of diagnosis of different forms of glomerulonephritis as cause of development and progression of chronic kidney disease in different regions of world, according to clinical and morphological studies with renal biopsy. Medical alphabet. 2021;(25):20-25. (In Russ.) https://doi.org/10.33667/2078-5631-2021-25-20-25
Views:
498
Email this article 